Skip to main content
PLOS One logoLink to PLOS One
. 2024 Oct 7;19(10):e0311677. doi: 10.1371/journal.pone.0311677

Quantifying the effect of interpregnancy maternal weight and smoking status changes on childhood overweight and obesity in a UK population-based cohort

Elizabeth J Taylor 1,2,3, Nida Ziauddeen 3,4, Ann Berrington 5, Keith M Godfrey 1,6, Nisreen A Alwan 3,4,7,*
Editor: Engelbert Adamwaba Nonterah8
PMCID: PMC11458013  PMID: 39374249

Abstract

Background

Maternal preconception and pregnancy exposures have been linked to offspring adiposity. We aimed to quantify the effect of changes in maternal weight and smoking status between pregnancies on childhood overweight/obesity (≥ 85th centile) and obesity (≥ 95th centile) rates in second children.

Methods

Records for 5612 women were drawn from a population-based cohort of routinely collected antenatal healthcare records (2003–2014) linked to measured child body mass index (BMI) age 4–5 years. We applied the parametric G-formula to estimate the effect of hypothetical changes between pregnancy-1 and pregnancy-2 compared to the natural course scenario (without change) on child-2 BMI.

Results

Observed overweight/obesity and obesity in child-2 at age 4–5 years were 22.2% and 8·5%, respectively. We estimated that if all mothers started pregnancy-2 with BMI 18·5–24·9 kg/m² and all smokers stopped smoking, then child-2 overweight/obesity and obesity natural course estimates of 22.3% (95% CI 21.2–23.5) and 8·3% (7·6–9·1), would be reduced to 18.5% (17.4–19.9) and 6.2% (5.5–7.0), respectively. For mothers who started pregnancy-1 with BMI 18·5–24·9 kg/m², if all smokers stopped smoking, child-2 overweight/obesity and obesity natural course estimates of 17.3% (16.0–18.6) and 5·9% (5·0–6·7) would be reduced to 16.0% (14.6–17.3) and 4·9% (4·1–5·7), respectively. For mothers who started pregnancy-1 with BMI ≥30 kg/m², if BMI was 18·5–24·9 kg/m² prior to pregnancy-2, child-2 overweight/obesity and obesity natural course estimates of 38.6% (34.7–42.3) and 17·7% (15·1–20·9) would be reduced to 31.3% (23.8–40.0) and 12.5 (8.3–17.4), respectively. If BMI was 25.0–29.9 kg/m² prior to pregnancy-2, these estimates would be 34.5% (29.4–40.4) and 14.6% (11.2–17.8), respectively.

Conclusion

Interventions supporting women to lose/maintain weight and quit smoking between pregnancies could help reduce rates of overweight/obesity and obesity in second children. The most effective interventions may vary by maternal BMI prior to the first pregnancy.

Introduction

In 2020, globally, 39 million children under 5 years old had overweight or obesity [1]. In the UK for the 2022/23 school year, the prevalence of obesity in children at age 5–6 years was 9.2% and at age 10–11 years this was 22.7% [2]. The prevalence of obesity was, however, more than double for children living in the most deprived areas compared with those living in the least deprived; for children aged 10–11 years, the prevalences were 30.2% and 13.1% respectively [2].

Children with overweight and obesity suffer from many psychological and physical co-morbidities, including emotional and behavioural disorders [3, 4]. Since overweight and obesity are difficult to reverse once established, the tracking of childhood adiposity into adulthood is of particular concern [5, 6] and once established, overweight and obesity are difficult to reverse [7]. The role of prevention is therefore key and this research considers this further in the context of modifiable exposures after the birth of the first child and before the conception of the second. During this time families are likely to be in frequent contact with healthcare professionals and this could therefore be an important opportunity to focus on the health of the whole family before a further pregnancy [810].

The developmental origins of health and disease concept links exposures during the period prior to and immediately following conception and during pregnancy to lasting effects on the developing fetus and subsequent susceptibility to non-communicable disease, including overweight and obesity [11, 12]. Maternal weight and smoking during pregnancy have both been linked to childhood adiposity [13, 14], and changes to maternal weight and smoking behaviour between successive pregnancies have been shown to affect overweight and obesity in the child born in the latter pregnancy [15].

We aimed to quantify the effect of hypothetical scenarios based around maternal weight and smoking change, singly and in combination, between the first and second pregnancy to estimate effects on the prevalence of second child overweight/obesity (≥ 85th centile) and obesity (≥ 95th centile) at age 4–5 years. We then stratified the analyses to examine if scenario results varied by maternal body mass index (BMI) at the start of the first pregnancy, since observed rates of overweight/obesity and obesity in second children differed when stratified in this way (Table 1). In doing so we aimed to ascertain if the most effective scenarios varied depending on a mother’s BMI at the start of her first pregnancy.

Table 1. Observed percentages of obesity and overweight/obesity recorded in second children at the age of 4–5 years, by maternal body mass index (BMI) at the start of the first pregnancy (P1).

Maternal BMI at the start of P1 n Obesity (≥ 95th centile) at age 4–5 years (%) Overweight/obesity (≥ 85th centile) at age 4–5 years (%)
18.5–24.9 kg/m2 3 409 5.84 17.19
25–29.9 kg/m2 1 466 10.23 25.85
30 kg/m2 or more 737 17.64 38.13

In the whole sample, observed child 2 obesity was 8.54%; observed child 2 overweight/obesity was 22.20%

Methods

Sample derivation

Data for this analysis were drawn from the SLOPE (Studying Lifecourse Obesity PrEdictors) study [16, 17]. This is a population-based anonymised linked cohort of prospectively collected routine antenatal and birth records for all births registered at the University Hospital Southampton (UHS), Hampshire, UK (accessed 18/06/2018). These records were then linked to child health data from two community National Health Service (NHS) trusts (Solent NHS Trust (accessed 16/08/2018) and Southern Health NHS Foundation Trust (accessed 14/11/2018) who provide child healthcare for the same area, and include National Child Measurement Programme (NCMP) [18] height and weight measurements recorded when children were between 4 and 5 years old.

Records for women with their first two successive singleton live birth pregnancies were included (2003–2014), where a height and weight measurement was recorded for the second child between 4 and 5 years of age. Fig 1 gives the derivation of the sample for this analysis from the maximum available sample (n = 6663). Exclusions were made from the maximum available sample where the first antenatal care appointment (ANA) for either pregnancy took place after 168 days (24 weeks) gestation, as assessed by ultrasound examination performed by a healthcare professional (HCP). These were likely to be high risk pregnancies referred in from elsewhere, and maternal weight measured at the ANA would have included an element of gestational weight gain [19]. Women who had BMI in the underweight range (< 18.5 kg/m2) at the start of one or both of their pregnancies, or who conceived one or both of their pregnancies through assisted reproductive technologies were also excluded to reduce the potential for any unmeasured residual confounding due to changes in health, and because weight gain in women with underweight may be regarded as a positive intervention. Over 84% of the maximum eligible sample of women (n = 5612) were included in this analysis (Fig 1).

Fig 1. Flowchart showing the derivation of the sample used in this analysis.

Fig 1

† Over 24 weeks, ‡ Below 22 weeks or over 43 weeks.

This analysis forms part of a research project approved by the University of Southampton Faculty of Medicine Ethics Committee (ID 24433) and the National Health Service Health Research Authority (IRAS 242031). All data were anonymised by the data owners before being accessed by the research team.

Exposure assessment

Maternal weight (kilograms (kg)) was objectively measured by a midwife at the first ANA for each pregnancy. In the UK, this is recommended to take place by 10 weeks gestation for an uncomplicated pregnancy [20]. Maternal height (metres (m)) and details of maternal smoking status (condensed to smoking/not smoking) were also collected at this appointment by self-report. Maternal BMI was subsequently derived (kg/m2).

BMI was categorised as healthy weight (from 18.5 to 24.9 kg/m2), overweight (from 25 to 29.9 kg/m2) or obese (30 kg/m2 or more). These categories reflect a slightly truncated form of the WHO classifications [21].

Outcome assessment

Children in state-maintained schools in England have their height and weight measured by school nurses when they are between 4 and 5 years old [18]. Where a measurement was recorded for a second child, BMI was derived (kg/m2) and converted to age- and sex- adjusted BMI z-scores using UK 1990 growth reference charts [22]. Overweight/obesity was defined as ≥ 85th centile (z-score of +1.04) and obesity was defined as ≥ 95th centile (z-score of +1.65) [23].

Covariate measurements

Maternal age (in years) was calculated from date of birth prior to extraction of the dataset, to maintain anonymity. Covariates collected by self-report at the first ANA for each pregnancy included maternal ethnicity (condensed to White, Mixed, Asian, Black/African/Caribbean, Chinese, other and not stated (or not asked)), highest level of maternal education (secondary (GCSE) level or below/ college (A level)/University level or above) and employment status (condensed to employed/not employed). Systolic blood pressure (SBP) (mmHg) was objectively measured by a midwife. Infant birthweight (grams) was objectively measured at birth by a HCP as part of routine care. Details of mode of delivery were also recorded at birth (condensed to caesarean section delivery/not caesarean section delivery). Gestational age was based on a routine dating ultrasound scan undertaken by a HCP which usually takes place between 11 weeks and 2 days and 14 weeks and 1 day gestation [24].

Hypothetical scenarios

We evaluated scenarios based on change in maternal weight and smoking status between the first and second pregnancy, both individually and in combination, as detailed in Table 2.

Table 2. The scenarios evaluated for this analysis.

Scenario number Description
0 Natural course scenario of no change
1 All women begin their second pregnancy with BMI between 18.5 and 24.9 kg/m2
2 All women begin their second pregnancy with BMI between 25 and 29.9kg/m2
3 All women begin their second pregnancy with BMI ≥ 30 kg/m2
4 All smokers stop smoking, and are not active smokers at the first ANA for the second pregnancy
5 [1] and [4] combined
6 [2] and [4] combined
7 [3] and [4] combined

Abbreviations: ANA, antenatal care appointment; BMI, body mass index

Analysis was initially undertaken in the whole sample and was then stratified by maternal BMI at the start of the first pregnancy since, as has already been noted, observed rates of second child overweight/obesity and obesity differed depending on maternal weight at the start of the first pregnancy.

Statistical analysis

Unadjusted comparisons were carried out using Chi-squared tests for categorical variables and ANOVA for continuous variables.

Table 1 shows observed rates of second child overweight/obesity and obesity by maternal weight at the start of the first pregnancy.

For this analysis the parametric G-formula was applied to estimate the effects of hypothetical scenarios to capture change between the first and second pregnancies (Table 2). The estimated prevalence of overweight/obesity and obesity in second children at age 4 to 5 years was calculated for each scenario using the R package gfoRmula [25].

This method of analysis is based on standard outcome regression modelling and, in brief, involves fitting causally ordered regression models to all the covariates, the exposures and the outcome [26]. It has recently been used to estimate the effects of interventions to prevent stroke [27], myocardial infarction [28] and cognitive impairment in older adults [29].

Models were then constructed to simulate the risk of second child overweight/obesity and obesity under each of the hypothetical scenarios (Table 2), using the observed values of the covariates at baseline and then estimating the values of the other covariates using parametric models. The values of the covariates were then set to the values specified in the hypothetical scenarios to estimate the predicted risk of overweight/obesity or obesity under each of these hypothetical scenarios. For each model, 250 non-parametric bootstrap samples were generated to estimate 95% confidence intervals.

Maternal ethnicity, highest level of educational attainment and employment status were included as baseline confounders, based on details collected at the start of the first pregnancy.

All analyses were performed using R [30].

Results

Characteristics of those included in this study

Table 3 shows characteristics of the women and infants included in this study, by maternal BMI at the start of the first pregnancy. Of women included in this analysis, 60.7% (n = 3409) began their first pregnancy with BMI between 18.5 and 24.9 kg/m2, 26.1% (n = 1466) had BMI between 25 and 29.9 kg/m2, and 13.1% (n = 737) had BMI ≥ 30kg/m2 at the start of their first pregnancy.

Table 3. Maternal, birth and child characteristics by maternal body mass index (BMI) at the start of the first pregnancy.

All figures are proportions (%), unless otherwise stated.

Maternal BMI at the start of the first pregnancy
18.5 to 24.9kg/m2 n = 3 409 25 to 29.9kg/m2 n = 1 466 ≥ 30kg/m2 n = 737 p-value1
Collected at the start of the first pregnancy
Age, years (mean, SD) 25.9 (5.5) 26.1 (5.2) 26.1 (5.2) 0.199
BMI, kg/m2 (mean, SD) 22.0 (1.7) 27.0 (1.4) 34.3 (4.0) < 0.001
SBP mmHg (mean, SD) 108.7 (10.6) 112.4 (10.5) 117.7 (10.8) < 0.001
(missing records) (n = 39) (n = 12) (n = 3)
Smoking status: 0.298
Not smoking 85.2 85.3 83.0
Smoking 14.8 14.7 17.0
Collected at the start of the second pregnancy
Age, years (mean, SD) 28.8 (5.5) 29.0 (5.2) 29.0 (5.2) 0.235
BMI, kg/m2 (mean, SD) 23.1 (2.7) 28.4 (3.5) 35.2 (5.3) < 0.001
SBP mmHg (mean, SD) 107.7 (10.2) 112.0 (10.4) 117.0 (10.7) < 0.001
(missing records) (n = 59) (n = 34) (n = 10)
Smoking status: 0.085
Not smoking 86.8 87.3 84.0
Smoking 13.2 12.8 16.0
Recorded at the first birth
Delivery by Caesarean section (%) 17.9 24.6 31.9 < 0.001
(missing records) (n = 9) (n = 2) (n = 1)
Birthweight, grams (mean, SD) 3342 (510) 3411 (532) 3500 (562) < 0.001
Gestational age, days (mean, SD)3 280 (12) 280 (13) 281 (14) 0.049
Recorded at the second birth
Delivery by Caesarean section (%) 14.7 21.5 28.0 < 0.001
(missing records) (n = 54) (n = 21) (n = 5)
Birthweight, grams (mean, SD) 3497 (501) 3587 (502) 3681 (551) < 0.001
Gestational age, days (mean, SD)3 280 (10) 281 (10) 281 (11) 0.003
Other details
Ethnicity: < 0.001
White 87.8 90.3 95.0
Mixed 0.9 0.9 1.1
Asian 4.6 2.9 0.9
Black/African/Caribbean 1.2 1.7 0.7
Chinese 0.6 0.1 0.0
Other 0.7 0.4 0.3
Not specified 4.2 3.8 2.0
Highest education level at baseline: < 0.001
University or above 30.2 25.2 21.0
College (A levels) 36.6 40.5 47.2
Secondary or below (GCSEs) 33.2 34.2 31.8
Employment at baseline: 0.022
In employment 83.5 85.5 87.1
Not in employment 16.5 14.5 12.9
(missing records) (n = 11) (n = 5) (n = 1)
Weight change between pregnancies: < 0.001
Weight stable (Gain or loss up to 1kg/m2) 41.3 28.8 23.7
Weight loss (Loss ≥ 1kg/m2) 12.7 20.1 26.3
Moderate gain (Gain ≥ 1 and < 3kg/m2) 30.1 25.9 22.9
High gain (Gain ≥ 3kg/m2) 15.9 25.3 27.0
Length of the interpregnancy interval2 0.174
< 12 months 17.5 14.9 19.0
12 to < 24 months 38.3 38.6 36.9
24 to < 36 months 23.3 25.8 24.2
36 months or more 20.9 20.7 19.9
First child at age 4–5 years
With obesity (≥ 95th centile) 5.7 8.3 12.7 < 0.001
Without obesity 94.3 91.7 87.3
(missing records) (n = 1451) (n = 669) (n = 313)
With overweight/obesity (≥ 85th centile) 15.9 23.8 31.1 < 0.001
Without overweight obesity 84.1 76.2 68.9
(missing records) (n = 1451) (n = 669) (n = 313)
Second child at age 4–5 years
With obesity (≥ 95th centile) 5.8 10.2 17.6 < 0.001
Without obesity 94.2 89.8 82.4
With overweight/obesity (≥ 85th centile) 17.2 25.9 38.1 < 0.001
Without overweight obesity 82.8 74.1 61.9

Abbreviations: BMI, body mass index; A level, Advanced level; GCSE, General Certificate of Secondary Education; SBP, systolic blood pressure; SD, standard deviation

1. p-values calculated using ANOVA for continuous and Chi-squared tests for categorical variables

2. From the birth of the first child to the conception of the second

3. 280 days gestation is equivalent to 40 weeks

At the start of their second pregnancy, 79.6% (n = 2714 of 3409) of women maintained a BMI in the range of 18.5–24.9 kg/m2, 56.1% (n = 823 of 1466) maintained a BMI in the range 25–29.9 kg/m2, and 87.2% (n = 643 of 737) maintained a BMI ≥ 30kg/m2.

Of those who started their first pregnancy with BMI ≥ 30 kg/m2, 1.5% (n = 11) started their second pregnancy with a BMI in the range of 18.5–24.9 kg/m2, and 11.3% (n = 83) with a BMI in the range of 25–29.9 kg/m2. Overall, 60.7% (n = 447) of women with BMI ≥ 30 kg/m2 gained weight from the start of their first to the start of their second pregnancy; 27.0% (n = 199) exhibited significant weight gain of ≥ 3 kg/m2. Whilst 36.2% (n = 267) of women in this category lost weight from the start of their first to the start of their second pregnancy, only 12.9% (n = 95) lost ≥ 3 kg/m2.

Second born children with obesity or overweight/obesity at age 4–5 years were more likely to have mothers who started their first or second pregnancies with obesity or overweight/obesity, who exhibited high weight gain (≥ 3 kg/m2) between pregnancies and who were smoking at the start of their first or second pregnancy.

Table 4 presents the analyses for each hypothetical scenario (Table 2), in the whole sample and then stratified by maternal BMI range at the start of the first pregnancy.

Table 4. The percentages of second children with obesity and overweight/obesity at age 4–5 years under different hypothetical scenarios, together with population risk ratios and population mean differences.

Scenario Number and Description 2nd children at age 4–5 years % (95% CI) Population risk ratio (95% CI) Population mean difference (95% CI)
Obesity Overweight/obesity Obesity Overweight/obesity Obesity Overweight/obesity
Analysis in the whole sample
[0] Natural course1 8.30 (7.59, 9.05) 22.22 (21.21, 23.47) 1.00 1.00 0.00 0.00
[1] BMI between 18.5 and 24.9 kg/m2 at the start of P2 6.63 (5.94, 7.42) 19.19 (18.16, 20.66) 0.80 (0.75, 0.84) 0.86 (0.84, 0.89) -1.67 (-2.08, -1.33) -3.04 (-3.67, -2.38)
[2] BMI between 25 and 29.9 kg/m2 at the start of P2 8.32 (7.63, 9.11) 22.65 (21.65, 23.90) 1.00 (0.99, 1.01) 1.02 (1.01, 1.03) 0.02 (-0.07, 0.12) 0.43 (0.30, 0.58)
[3] BMI ≥ 30 kg/m2 at the start of P2 10.53 (9.50, 11.60) 26.85 (25.29, 28.44) 1.27 (1.21, 1.34) 1.21 (1.17, 1.25) 2.23 (1.71, 2.81) 4.63 (3.70, 5.62)
[4] All smokers quit 7.72 (6.96. 8.56) 21.43 (20.41, 22.73) 0.93 (0.89, 0.98) 0.96 (0.94, 0.99) -0.58 (-0.92, -0.18) -0.80 (-1.36, 0.32)
[5] Scenarios [1] and [4] combined 6.16 (5.50, 6.95) 18.46 (17.42, 19.86) 0.74 (0.69, 0.79) 0.83 (0.80, 0.87) -2.14 (-2.60, -1.68) -3.76 (-4.49, -3.00)
[6] Scenarios [2] and [4] combined 7.74 (7.00, 8.60) 21.84 (20.83, 23.23) 0.93 (0.89, 0.98) 0.98 (0.96, 1.01) -0.56 (-0.89, -0.13) -0.39 (-0.91, 0.12)
[7] Scenarios [3] and [4] combined 9.82 (8.73, 10.96) 25.96 (24.33, 27.72) 1.18 (1.10, 1.28) 1.17 (1.11, 1.22) 1.52 (0.82, 2.33) 3.73 (2.51, 4.84)
Analysis in the group of women who started their first pregnancy with BMI in the healthy range (between 18.5 and 24.9 kg/m2)
[0] Natural course2 5.85 (5.03, 6.68) 17.32 (15.96, 18.58) 1.00 1.00 0.00 0.00
[1] BMI between 18.5 and 24.9 kg/m2 at the start of P2 5.52 (4.67, 6.34) 16.86 (15.49, 18.20) 0.94 (0.91, 0.97) 0.97 (0.96, 0.99) -0.32 (-0.49, -0.17) -0.46 (-0.66, -0.24)
[2] BMI between 25 and 29.9 kg/m2 at the start of P2 7.15 (6.14, 8.28) 19.56 (17.96, 21.22) 1.22 (1.12, 1.32) 1.13 (1.07, 1.19) 1.30 (0.73, 1.88) 2.24 (1.23, 3.21)
[3] BMI ≥ 30 kg/m2 at the start of P2 11.35 (8.41, 15.12) 25.25 (21.35, 29.41) 1.94 (1.44, 2.57) 1.46 (1.24, 1.68) 5.50 (2.68, 8.94) 7.93 (4.12, 11.83)
[4] All smokers quit 4.87 (4.07, 5.70) 16.03 (14.60, 17.25) 0.83 (0.77, 0.90) 0.93 (0.89, 0.96) -0.97 (-1.38, -0.56) -1.29 (-1.91, -0.64)
[5] Scenarios [1] and [4] combined 4.60 (3.85, 5.43) 15.60 (14.19, 16.80) 0.79 (0.72, 0.85) 0.90 (0.86, 0.93) -1.25 (-1.64, -0.87) -1.72 (-2.42, -1.10)
[6] Scenarios [2] and [4] combined 5.99 (4.99, 7.17) 18.17 (16.50, 19.77) 1.03 (0.91, 1.16) 1.05 (0.98, 1.12) 0.15 (-0.55, 0.89) 0.85 (-0.27, 2.09)
[7] Scenarios [3] and [4] combined 9.65 (7.01, 13.29) 23.62 (19.78, 27.66) 1.65 (1.21, 2.24) 1.36 (1.15, 1.58) 3.81 (1.30, 7.36) 6.30 (2.63, 10.12)
Analysis in the group of women who started their first pregnancy with BMI in the overweight range (between 25 and 29.9 kg/m2)
[0] Natural course3 9.81 (8.38, 11.27) 25.65 (23.50, 28.15) 1.00 1.00 0.00 0.00
[1] BMI between 18.5 and 24.9 kg/m2 at the start of P2 9.80 (7.48, 12.20) 25.27 (21.91, 29.25) 1.00 (0.83, 1.18) 0.99 (0.89, 1.10) -0.01 (-1.50, 1.71) -0.38 (-3.02, 2.60)
[2] BMI between 25 and 29.9 kg/m2 at the start of P2 9.81 (8.29, 11.29) 25.59 (23.38, 28.07) 1.00 (0.97, 1.02) 1.00 (0.98, 1.01) 0.00 (-0.30, 0.21) -0.05 (-0.46, 0.31)
[3] BMI ≥ 30 kg/m2 at the start of P2 9.82 (8.11, 11.41) 25.86 (22.79, 28.44) 1.00 (0.91, 1.09) 1.01 (0.94, 1.07) 0.00 (-0.90, 0.80) 0.21 (-1.50, 1.75)
[4] All smokers quit 9.62 (8.04, 11.39) 25.28 (22.94, 28.03) 0.98 (0.91, 1.05) 0.99 (0.95, 1.02) -0.19 (-0.89, 0.46) -0.37 (-1.24, 0.56)
[5] Scenarios [1] and [4] combined 9.62 (7.17, 12.31) 24.91 (21.47, 28.70) 0.98 (0.78, 1.18) 0.97 (0.86, 1.08) -0.20 (-2.02, 1.75) -0.74 (-3.64, 2.05)
[6] Scenarios [2] and [4] combined 9.62 (8.02, 11.39) 25.22 (22.82, 27.87) 0.98 (0.90, 1.05) 0.98 (0.94, 1.02) -0.19 (-0.97, 0.51) -0.42 (-1.43, 0.56)
[7] Scenarios [3] and [4] combined 9.63 (7.82, 11.15) 25.49 (22.36, 28.51) 0.98 (0.85, 1.09) 0.99 (0.91, 1.06) -0.18 (-1.41, 0.84) -0.16 (-2.33, 1.50)
Analysis in the group of women who started their first pregnancy with BMI in the obese range (≥ 30 kg/m2)
[0] Natural course4 17.74 (15.05, 20.89) 38.60 (34.74, 42.28) 1.00 1.00 0.00 0.00
[1] BMI between 18.5 and 24.9 kg/m2 at the start of P2 12.52 (8.28, 17.41) 31.31 (23.76, 39.92) 0.71 (0.47, 0.95) 0.81 (0.63, 0.99) -5.22 (-9.65, -0.88) -7.29 (-14.70, -0.30)
[2] BMI between 25 and 29.9 kg/m2 at the start of P2 14.62 (11.17, 17.81) 34.45 (29.39, 40.42) 0.82 (0.65, 0.97) 0.89 (0.78, 1.00) -3.12 (-6.20, -0.50) -4.15 (-8.70, -0.17)
[3] BMI ≥ 30 kg/m2 at the start of P2 17.94 (15.19, 21.17) 38.90 (34.87, 42.73) 1.01 (1.00, 1.02) 1.00 (1.00, 1.01) 0.21 (0.04, 0.36) 0.30 (0.01, 0.55)
[4] All smokers quit 18.06 (15.30, 21.45) 39.27 (35.08, 43.39) 1.02 (0.94, 1.10) 1.02 (0.97, 1.07) 0.32 (-0.97, 1.70) 0.67 (-1.07, 2.72)
[5] Scenarios [1] and [4] combined 12.76 (8.49, 17.33) 31.92 (23.89, 40.80) 0.72 (0.46, 0.97) 0.83 (0.64, 1.01) -4.98 (-9.53, -0.53) -6.68 (-14.30, 0.49)
[6] Scenarios [2] and [4] combined 14.89 (11.37, 18.26) 35.09 (29.60, 41.15) 0.84 (0.65, 1.00) 0.91 (0.78, 1.02) -2.85 (-6.08, -0.04) -3.51 (-8.52, 0.67)
[7] Scenarios [3] and [4] combined 18.27 (15.46, 21.72) 39.57 (35.10, 43.71) 1.03 (0.95, 1.11) 1.03 (0.98, 1.07) 0.53 (-0.88, 2.00) 0.97 (-0.72, 2.97)

Abbreviations: BMI, body mass index; CI, confidence intervals; P2, the second pregnancy

Obesity defined as ≥ 95th centile; Overweight/obesity defined as ≥ 85th centile

No active smokers at the first antenatal care appointment for the second pregnancy

1. Observed obesity 8.54%; observed overweight/obesity 22.20%

2. Observed obesity 5.84%; observed overweight/obesity 17.19%

3. Observed obesity 10.23%; observed overweight/obesity was 25.85%

4. Observed obesity 17.64%; observed overweight/obesity was 38.13%

Results for the whole sample

In the whole sample, scenarios 1 and 5 showed the greatest impact in reducing the prevalence of obesity and overweight/obesity in second children at age 4 to 5 years. Scenarios 1 and 5 both include starting the second pregnancy with BMI 18.5–24.9 kg/m2; when considered as the only change (scenario 1), there would be a 20.1% (95% confidence interval (CI) 16.0, 24.5) population risk reduction in obesity to 6.6% (5.9, 7.4) and a 13.7% (10.9, 16.3) population risk reduction in overweight/obesity to 19.2% (18.2, 20.7), compared to the NCE (scenario 0).

Results for women who started their first pregnancy with BMI 18.5–24.9 kg/m2

In the sample of women who started their first pregnancy with BMI 18.5–24.9 kg/m2, scenarios 4 and 5 had the greatest impact in reducing the prevalence of obesity and overweight/obesity in second children at age 4 to 5 years. Scenarios 4 and 5 both include smokers having stopped smoking by the first ANA for the second pregnancy; when considered as the only change there would be a 16.7% (10.0, 23.2) population risk reduction in obesity to 4.9% (4.1, 5.7) and a 7.4% (3.9, 11.0) population risk reduction in overweight/obesity to 16.0% (14.6, 17.3), compared to the NCE (scenario 0).

Results for women who started their first pregnancy with BMI 25–29.9 kg/m2

In the sample of women who started their first pregnancy with BMI 25–29.9 kg/m2, none of the scenarios produced significant results, compared to the NCE (scenario 0).

Results for women who started their first pregnancy with BMI ≥ 30 kg/m2

In the sample of women who started their first pregnancy with BMI ≥ 30 kg/m2 the scenarios with the greatest impact in reducing the prevalence of obesity and overweight/obesity in second children at age 4 to 5 years all included weight reduction by the start of the second pregnancy. When starting the second pregnancy with a BMI of 18.5–24.9 kg/m2 as the only change there would be a 29.4% (4.7, 53.4) population risk reduction in obesity to 12.5% (8.3, 17.4) and a 18.9% (0.8, 36.9) population risk reduction in overweight/obesity to 31.3% (23.8, 39.9), compared to the NCE (scenario 0). When starting the second pregnancy with a BMI of 25–29.9 kg/m2 as the only change there would be a 17.6% (2.6, 35.1) population risk reduction in obesity to 14.6% (11.2, 17.8) and a 10.8% (0.4, 22.0) population risk reduction in overweight/obesity to 34.5% (29.4, 40.4), compared to the NCE (scenario 0).

Discussion

According to this analysis, changes after the birth of the first child and before the conception of the second could play an important role in reducing overweight/obesity and obesity rates in second children at the start of primary school. The most effective scenarios may vary by maternal BMI at the start of the first pregnancy. Weight maintenance in women who start their first pregnancy with BMI in the range of 18.5–24.9 kg/m2 is important, but for this group of women smoking cessation was the scenario with the greatest effect. Conversely, whilst smoking cessation would be beneficial for many reasons in the group of women who started their first pregnancy with BMI in the obese range, weight loss in the interconception period had the greatest impact.

Cessation of smoking prior to pregnancy is known to be beneficial since maternal smoking increases the risk of miscarriage, stillbirth, prematurity and fetal growth restriction [31]. Longer term, where a fetus has been exposed to maternal smoking, there is a higher risk of childhood overweight and obesity [14], and children of maternal smokers have higher central adiposity than the children of non-smokers [32]. In the UK, HCPs are able to refer pregnant smokers to smoking cessation services and this should certainly be encouraged. Intervention during the interpregnancy interval may help prevent re-uptake or inception of smoking prior to the next pregnancy. Intervention at the earliest stage may also help to reduce the risk of other adverse outcomes, for example SGA birth, which in turn has been associated with offspring adiposity [6].

Childhood obesity risk is increased in mothers with obesity, and animal models have demonstrated that maternal over-nutrition from a high fat diet can predict obesity in adulthood, independent of post-natal diet [33, 34]. The worldwide increasing prevalence of obesity in women of reproductive age is a major concern, and may impact not only maternal health but also that of any future children [35]. Overweight and obesity in pregnancy increases the risk of pregnancy and birth related complications [36], which can, in turn, lead to increased risks of childhood overweight and obesity. These complications include developing gestational diabetes [35, 37], having an infant with high birthweight or who is born large for their gestational age [33, 38] and requiring a caesarean section delivery [36, 39].

Only 35.7% of the women in this analysis (n = 2,005) remained weight stable between pregnancies (defined here as a difference of a gain or loss of up to 1 kg/m2). More than a quarter of mothers who started their first pregnancy with BMI in either the overweight or obese range showed high weight gain between their first two pregnancies (defined here as a gain of 3 kg/m2 or more). These categories have been selected to be consistent with previous literature as a way of enabling a straightforward comparison of weight change between pregnancies [40]. This analysis provides evidence to suggest that more awareness of the benefits of returning to a healthy weight after pregnancy could have an effect on the long-term health of subsequent children, particularly when a mother started her first pregnancy with obesity. It is, of course, not as simple as promoting awareness. There are other barriers to returning to a healthy weight [41], shaped by wider socio-economic and environmental factors. This includes the impact of the built environment, a potential lack of available greenspace, the cost of healthy foods, access to unhealthy food outlets, the necessity of travelling further distances to retail outlets selling healthier options and a lack of time and resources to acquire, cook or eat healthier food items. Strategies which support women returning to, or reaching, a healthy weight need to take account of the fact that high weight loss between pregnancies has itself been associated with childhood adiposity [15] and also with increased risk of other adverse outcomes including preterm and SGA birth [40, 42, 43]. SGA birth in conjunction with rapid postnatal catch up growth, is also associated with childhood adiposity [33].

We found that in women who started their first pregnancies with BMI of 18.5–24.9 kg/m2, smoking cessation combined with weight maintenance was the most effective scenario in reducing the risk of offspring overweight or obesity. Whilst smoking cessation is also to be strongly encouraged in women who start their first pregnancies with BMI in the obese range, here reducing weight between pregnancies was the most effective scenario to prevent second child overweight/obesity and obesity. Interventions based around weight maintenance and a steady return to pre-pregnancy weight prior to conceiving again are therefore to be encouraged.

Optimising maternal health between consecutive pregnancies will not only ensure that a mother is well prepared for her next pregnancy and birth but may also help to improve the longer-term health of her child [44]. Interventions during the post-partum period, which is the preconception period for a subsequent pregnancy, may be possible since a mother is still in frequent contact with HCPs during that time. It may be also be possible to incorporate timely interventions within Women’s Health Hubs in England, which aim to provide easily accessible and holistic care to women throughout their lives [45].

A recent systematic review which considered the effectiveness of interventions delivered by HCPs during the period from conception to a child’s second birthday (the first 1,000 days) did find evidence that a few were effective in reducing childhood adiposity [46]. Whether HCPs have the time during existing appointments with young families in which to deliver such interventions will also need to be considered, and any interventions which are based around maternal weight will need careful consideration to ensure that existing inequalities based around access to healthy food, for example, are not widened [47, 48].

Strengths and limitations of this study

Strengths of this study include drawing on data from the SLOPE study, a large population-based cohort that is representative of the local population. It includes women from all socio-economic and ethnic backgrounds. The analysis adjusted for several key confounders, a number of which were objectively measured by HCPs. Maternal BMI measurements, which form part of the exposures considered, were based on objectively measured maternal weight at the start of each pregnancy. Outcome measurements were also objectively measured and recorded by school nurses as part of the NCMP in schools.

There are some limitations, including the collection of information by self-report. This includes maternal smoking status at the start of each pregnancy and raises the possibility of non-disclosure and information bias. In addition, the NCMP is an opt-out scheme and some parents may not have allowed their children to be part of the process. Participation rates are high, however, with over 95% of children participating annually [49].

Whilst the application of the parametric G-formula in this analysis enabled the consideration of a number of hypothetical scenarios capturing change between pregnancies and enabled a comparison of scenarios based on maternal BMI at the start of the first pregnancy, future analyses should consider additional scenarios.

Conclusion

Interventions after the birth of the first child and before the conception of the second child could reduce the prevalence of overweight/obesity and obesity in second and subsequent children at the age of 4 to 5 years. The most effective interventions may vary by maternal BMI at the start of the first pregnancy. The time between pregnancies, when women are still in regular contact with HCPs is an important opportunity for well-timed interventions which could impact the health of the whole family. Using maternal BMI at the start of the first pregnancy to group women could enable HCPs to identify groups where additional support might be offered. Support to encourage mothers who had healthy weight at the start of their first pregnancy to quit smoking and maintain their weight, and support mothers who had obesity at the start of their first pregnancy to lose weight between pregnancies could have the greatest impact the health of mothers and their children.

Acknowledgments

We thank David Cable (Electronic Patient Records Implementation and Service Manager) and Florina Borca (Senior Information Analyst R&D) at University Hospital Southampton for support in accessing the data used in this study. We thank Gareth Edwards (Business Intelligence Developer at Solent NHS Trust) as well as the Research and Development and data team at Southern Health NHS Foundation Trust for their help in access the early life data used in this study.

Data Availability

The study’s ethical approval from the Faculty of Medicine Ethics Committee, University of Southampton and the Health Research Authority restricts public sharing of the raw data used in this study. To request access conditional on approval from the appropriate institutional ethics, research governance processes and data owners, please email rgoinfo@soton.ac.uk.

Funding Statement

This work is supported by an Academy of Medical Sciences and Wellcome Trust Grant [AMS_HOP001\1060 to NAA] and an NIHR Southampton Biomedical Research and University of Southampton Primary Care, Population Sciences and Medical Education PhD studentship to EJT. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. KMG is supported by the UK Medical Research Council (MC_UU_12011/4), the National Institute for Health Research (NIHR Senior Investigator (NF-SI-0515-10042), NIHR Southampton 1000DaysPlus Global Nutrition Research Group (17/63/154) and NIHR Southampton Biomedical Research Centre (IS-BRC-1215-20004)), the European Union (Erasmus+ Programme Early Nutrition eAcademy Southeast Asia-573651-EPP-1-2016-1-DE-EPPKA2-CBHE-JP and ImpENSA 598488-EPP-1-2018-1-DE-EPPKA2-CBHE-JP), the British Heart Foundation (RG/15/17/3174), the US National Institute On Aging of the National Institutes of Health (Award No. U24AG047867) and the UK ESRC and BBSRC (Award No. ES/M00919X/1).

References

  • 1.World Health Organisation. Obesity and Overweight [Internet]. 2018 [cited 2023 Oct 9]. https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight
  • 2.NHS Digital. National Child Measurement Programme, England, 2022/23 school Year [Internet]. 2023. https://digital.nhs.uk/data-and-information/publications/statistical/national-child-measurement-programme/2022-23-school-year
  • 3.Di Cesare M, Sorić M, Bovet P, Miranda JJ, Bhutta Z, Stevens GA, et al. The epidemiological burden of obesity in childhood: a worldwide epidemic requiring urgent action. BMC Med. 2019. Nov 25;17(1):212. doi: 10.1186/s12916-019-1449-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Sutaria S, Devakumar D, Yasuda SS, Das S, Saxena S. Is obesity associated with depression in children? Systematic review and meta-analysis. Arch Dis Child. 2019. Jan;104(1):64–74. doi: 10.1136/archdischild-2017-314608 [DOI] [PubMed] [Google Scholar]
  • 5.Lake JK, Power C, Cole TJ. Child to adult body mass index in the 1958 British birth cohort: associations with parental obesity. Arch Dis Child. 1997;77(5):376. doi: 10.1136/adc.77.5.376 [DOI] [PubMed] [Google Scholar]
  • 6.Juonala M, Magnussen CG, Berenson GS, Venn A, Burns TL, Sabin MA, et al. Childhood Adiposity, Adult Adiposity, and Cardiovascular Risk Factors. N Engl J Med. 2011. Nov 17;365(20):1876–85. doi: 10.1056/NEJMoa1010112 [DOI] [PubMed] [Google Scholar]
  • 7.Lanigan J. Prevention of overweight and obesity in early life. Proc Nutr Soc. 2018. Aug;77(3):247–56. doi: 10.1017/S0029665118000411 [DOI] [PubMed] [Google Scholar]
  • 8.Stephenson J, Heslehurst N, Hall J, Schoenaker DAJM, Hutchinson J, Cade JE, et al. Before the beginning: nutrition and lifestyle in the preconception period and its importance for future health. Lancet Lond Engl. 2018. May 5;391(10132):1830–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Fleming TP, Watkins AJ, Velazquez MA, Mathers JC, Prentice AM, Stephenson J, et al. Origins of lifetime health around the time of conception: causes and consequences. Lancet Lond Engl. 2018. May 5;391(10132):1842–52. doi: 10.1016/S0140-6736(18)30312-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Barker M, Dombrowski SU, Colbourn T, Fall CHD, Kriznik NM, Lawrence WT, et al. Intervention strategies to improve nutrition and health behaviours before conception. The Lancet. 2018. May;391(10132):1853–64. doi: 10.1016/S0140-6736(18)30313-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Sun C, Velazquez MA, Fleming TP. Chapter 3—DOHaD and the Periconceptional Period, a Critical Window in Time. In: Rosenfeld CS, editor. The Epigenome and Developmental Origins of Health and Disease. Boston: Academic Press; 2016. p. 33–47. [Google Scholar]
  • 12.Gluckman PD, Buklijas T, Hanson MA. Chapter 1—The Developmental Origins of Health and Disease (DOHaD) Concept: Past, Present, and Future. In: Rosenfeld CS, editor. The Epigenome and Developmental Origins of Health and Disease. Boston: Academic Press; 2016. p. 1–15.
  • 13.Heslehurst N, Vieira R, Akhter Z, Bailey H, Slack E, Ngongalah L, et al. The association between maternal body mass index and child obesity: A systematic review and meta-analysis. PLOS Med. 2019;16(6):e1002817. doi: 10.1371/journal.pmed.1002817 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Rayfield S, Plugge E. Systematic review and meta-analysis of the association between maternal smoking in pregnancy and childhood overweight and obesity. J Epidemiol Community Health. 2017;71(2):162. doi: 10.1136/jech-2016-207376 [DOI] [PubMed] [Google Scholar]
  • 15.Taylor EJ, Wilding S, Ziauddeen N, Godfrey KM, Berrington A, Alwan NA. Change in modifiable maternal characteristics and behaviours between consecutive pregnancies and offspring adiposity: A systematic review. Obes Rev. 2020. May 29;1–15. doi: 10.1111/obr.13048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Wilding S, Ziauddeen N, Smith D, Roderick P, Chase D, Alwan NA. Are environmental area characteristics at birth associated with overweight and obesity in school-aged children? Findings from the SLOPE (Studying Lifecourse Obesity PrEdictors) population-based cohort in the south of England. BMC Med. 2020. Mar 19;18(1):43. doi: 10.1186/s12916-020-01513-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Ziauddeen N, Roderick PJ, Santorelli G, Alwan NA. Prediction of childhood overweight and obesity at age 10–11: findings from the Studying Lifecourse Obesity PrEdictors and the Born in Bradford cohorts. Int J Obes [Internet]. 2023. Aug 4; doi: 10.1038/s41366-023-01356-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.NHS Digital [Internet]. [cited 2021 Aug 26]. National Child Measurement Programme, England 2018/19 School Year [NS]. https://digital.nhs.uk/data-and-information/publications/statistical/national-child-measurement-programme/2018-19-school-year
  • 19.nhs.uk [Internet]. 2020 [cited 2021 Aug 25]. Weight gain in pregnancy. https://www.nhs.uk/pregnancy/related-conditions/common-symptoms/weight-gain/
  • 20.Antenatal care overview—NICE Pathways [Internet]. [cited 2021 Oct 9]. https://pathways.nice.org.uk/pathways/antenatal-care#content=view-node%3Anodes-planning-antenatal-appointments-and-record-keeping
  • 21.World Health Organization. A healthy lifestyle—WHO recommendations [Internet]. 2010. https://www.who.int/europe/news-room/fact-sheets/item/a-healthy-lifestyle---who-recommendations
  • 22.Vidmar SI, Cole TJ, Pan H. Standardizing Anthropometric Measures in Children and Adolescents with Functions for Egen: Update. Stata J. 2013. Jul 1;13(2):366–78. [Google Scholar]
  • 23.Yumpu.com. yumpu.com. [cited 2021 Aug 26]. A simple guide to classifying body mass index in children—National… https://www.yumpu.com/en/document/view/28558081/a-simple-guide-to-classifying-body-mass-index-in-children-national-
  • 24.Routine antenatal care—NICE Pathways [Internet]. [cited 2021 Aug 26]. https://pathways.nice.org.uk/pathways/antenatal-care#path=view%3A/pathways/antenatal-care/routine-antenatal-care.xml&content=view-node%3Anodes-routine-ultrasound-scans
  • 25.Lin V, McGrath S, Zhang Z, Logan RW, Petito LC, Young JG, et al. gfoRmula: Parametric G-Formula. R package version 0.3.1. https://CRAN.R-project.org/package=gfoRmula [Internet]. [DOI] [PMC free article] [PubMed]
  • 26.Mansournia MA, Etminan M, Danaei G, Kaufman JS, Collins G. Handling time varying confounding in observational research. BMJ. 2017/10/19 ed. 2017. Oct 16;359:j4587. doi: 10.1136/bmj.j4587 [DOI] [PubMed] [Google Scholar]
  • 27.Vangen-Lønne AM, Ueda P, Gulayin P, Wilsgaard T, Mathiesen EB, Danaei G. Hypothetical interventions to prevent stroke: an application of the parametric g-formula to a healthy middle-aged population. Eur J Epidemiol. 2018. Jun;33(6):557–66. doi: 10.1007/s10654-017-0344-x [DOI] [PubMed] [Google Scholar]
  • 28.Wilsgaard T, Vangen-Lønne AM, Mathiesen E, Løchen ML, Njølstad I, Heiss G, et al. Hypothetical interventions and risk of myocardial infarction in a general population: application of the parametric g-formula in a longitudinal cohort study—the Tromsø Study. BMJ Open. 2020. May 24;10(5):e035584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Zhou Z, Cai L, Fu J, Han Y, Fang Y. Hypothetical Interventions on Risk Factors for Cognitive Impairment among Chinese Older Adults: An Application of the Parametric G-Formula. Int J Environ Res Public Health. 2020. Feb;17(3):1021. doi: 10.3390/ijerph17031021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.R: The R Project for Statistical Computing [Internet]. [cited 2021 Sep 7]. https://www.r-project.org/
  • 31.Cnattingius S. The epidemiology of smoking during pregnancy: Smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res. 2004;6(Suppl_2):S125–40. doi: 10.1080/14622200410001669187 [DOI] [PubMed] [Google Scholar]
  • 32.Magriplis E, Farajian P, Panagiotakos DB, Risvas G, Zampelas A. Maternal smoking and risk of obesity in school children: Investigating early life theory from the GRECO study. Prev Med Rep. 2017;8:177–82. doi: 10.1016/j.pmedr.2017.10.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Desai M, Beall M, Ross MG. Developmental origins of obesity: programmed adipogenesis. Curr Diab Rep. 2013;13(1):27–33. doi: 10.1007/s11892-012-0344-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Howie GJ, Sloboda DM, Kamal T, Vickers MH. Maternal nutritional history predicts obesity in adult offspring independent of postnatal diet. J Physiol. 2008/12/22 ed. 2009;587(Pt 4):905–15. doi: 10.1113/jphysiol.2008.163477 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Hanson M, Gluckman P, Bustreo F. Obesity and the health of future generations. Lancet Diabetes Endocrinol. 2016;4(12):966–7. doi: 10.1016/S2213-8587(16)30098-5 [DOI] [PubMed] [Google Scholar]
  • 36.Valsamakis G, Kyriazi EL, Mouslech Z, Siristatidis C, Mastorakos G. Effect of maternal obesity on pregnancy outcomes and long-term metabolic consequences. Hormones. 2015. Jul 1;14(3):345–57. doi: 10.14310/horm.2002.1590 [DOI] [PubMed] [Google Scholar]
  • 37.Wang J, Wang L, Liu H, Zhang S, Leng J, Li W, et al. Maternal Gestational Diabetes and Different Indicators of Childhood Obesity—A Large Study. Endocr Connect. 2018;7(12):1464–71. doi: 10.1530/EC-18-0449 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Hong YH, Lee JE. Large for Gestational Age and Obesity-Related Comorbidities. J Obes Metab Syndr. 2021. Jun 30;30(2):124–31. doi: 10.7570/jomes20130 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Kuhle S, Tong OS, Woolcott CG. Association between caesarean section and childhood obesity: a systematic review and meta-analysis. Obes Rev. 2015. Apr 1;16(4):295–303. doi: 10.1111/obr.12267 [DOI] [PubMed] [Google Scholar]
  • 40.Grove G, Ziauddeen N, Harris S, Alwan NA. Maternal interpregnancy weight change and premature birth: Findings from an English population-based cohort study. PLOS ONE. 2019;14(11):e0225400. doi: 10.1371/journal.pone.0225400 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Hollis JL, Crozier SR, Inskip HM, Cooper C, Godfrey KM, Harvey NC, et al. Modifiable risk factors of maternal postpartum weight retention: an analysis of their combined impact and potential opportunities for prevention. Int J Obes 2005. 2017. Jul;41(7):1091–8. doi: 10.1038/ijo.2017.78 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Oteng-Ntim E, Mononen S, Sawicki O, Seed PT, Bick D, Poston L. Interpregnancy weight change and adverse pregnancy outcomes: a systematic review and meta-analysis. BMJ Open. 2018/06/06 ed. 2018. Jun 4;8(6):e018778. doi: 10.1136/bmjopen-2017-018778 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Wallace JM, Bhattacharya S, Campbell DM, Horgan GW. Inter-pregnancy weight change impacts placental weight and is associated with the risk of adverse pregnancy outcomes in the second pregnancy. BMC Pregnancy Childbirth. 2014. Jan 22;14(1):40. doi: 10.1186/1471-2393-14-40 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Watson D, Jacob CM, Giles G, McAuliffe FM, Godfrey K, Hanson M. A scoping review of nutritional interventions and policy guidelines in the interconception period for prevention of noncommunicable diseases. Reprod Female Child Health. 2022. Sep;1(1):18–41. [Google Scholar]
  • 45.Department of Health and Social Care. Women’s health hubs: core specification [Internet]. 2024. https://www.gov.uk/government/publications/womens-health-hubs-information-and-guidance/womens-health-hubs-core-specification
  • 46.Hennessy M, Heary C, Laws R, van Rhoon L, Toomey E, Wolstenholme H, et al. The effectiveness of health professional-delivered interventions during the first 1000 days to prevent overweight/obesity in children: A systematic review. Obes Rev. 2019;20(12):1691–707. doi: 10.1111/obr.12924 [DOI] [PubMed] [Google Scholar]
  • 47.Alwan NA, Grove G, Taylor E, Ziauddeen N. Maternal weight change between successive pregnancies: an opportunity for lifecourse obesity prevention. Proc Nutr Soc. 2020/06/22 ed. 2020;79(3):272–82. doi: 10.1017/S0029665120007065 [DOI] [PubMed] [Google Scholar]
  • 48.Ziauddeen N, Huang JY, Taylor E, Roderick PJ, Godfrey KM, Alwan NA. Interpregnancy weight gain and childhood obesity: analysis of a UK population-based cohort. Int J Obes. 2022. Jan 1;46(1):211–9. doi: 10.1038/s41366-021-00979-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.NHS Digital [Internet]. [cited 2021 Sep 28]. National Child Measurement Programme, England 2019/20 School Year. https://digital.nhs.uk/data-and-information/publications/statistical/national-child-measurement-programme/2019-20-school-year

Decision Letter 0

Engelbert Adamwaba Nonterah

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

31 Jul 2024

PONE-D-24-08911Quantifying the effect of interpregnancy maternal weight and smoking status changes on childhood overweight and obesity in a UK population-based cohortPLOS ONE

Dear Dr. Ziauddeen,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 14 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Engelbert A. Nonterah, MD, PhD

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We noted in your submission details that a portion of your manuscript may have been presented or published elsewhere. [This work was presented at the virtual Lancet Public Health Science conference in November 2021 and the submitted abstract was published (https://doi.org/10.1016/S0140-6736(21)02627-1). This work originally formed part of the thesis for a Doctor of Philosophy degree undertaken by Elizabeth Taylor and funded by NIHR Southampton Biomedical Research Centre and University of Southampton Primary Care, Population Sciences and Medical Education PhD studentship. The thesis is under embargo until October 2024.] Please clarify whether this [conference proceeding or publication] was peer-reviewed and formally published. If this work was previously peer-reviewed and published, in the cover letter please provide the reason that this work does not constitute dual publication and should be included in the current manuscript.

3. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

Please update your Data Availability statement in the submission form accordingly

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Reviewer’s comments

Introduction

� The introduction is clear and concise, but the literature cited is very global, none on the context where the study is conducted. Suggestion: include more contextual information including the problem and the gaps that the study addresses.

Methods

� Very well and clearly detailed.

Results

� Well detailed, aligned with the objectives and statistical analysis. However, quite difficult to follow, the author should add sub-topics representing the different sub-objectives / scenarios for clarity.

Reviewer #2: An excellent paper. Well written, conceived and interesting. Results support the need for good pre- / inter-conception strategies to optimise maternal health and mitigate childhood risks.

A few minor comments and suggests for the author(s):

Methods:

1. What is your rationale for excluding women who conceived via artificial reproductive therapy? This should be more clearly described and discussed in the paper. With increasing maternal age, more women are seeking to conceive via ART. Often BMI restrictions in the private sector are less closely adhered to than in the NHS. It is important that full representation of the pregnant population is described.

2. Exposure assessment - please state that the chosen BMI classes reflect a truncated WHO classification (REF).

Results:

1. Table 3: gestational age could be more meaningful to present as weeks and days depending on readership. It may be clearer to include both this in additional to gestational age in days.

2. Table 3: please check that units are clearly presented for all variables (e.g) weight change between pregnancies (%) in table 3.

3. Abbreviations 3 and 4 are not described in the footnotes for table 3, please amend.

4. What was your rationale for significant weight gain (3 kg or more)? Please describe why in the manuscript.

Discussion:

Well thought through and presented. Further discussion could include influence of recent maternity and public health strategies to support your proposed interventions. For example, the Women’s Health Strategy for England.

https://www.gov.uk/government/publications/womens-health-hubs-information-and-guidance/womens-health-hubs-core-specification

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Dr Kelly-Ann Eastwood

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Oct 7;19(10):e0311677. doi: 10.1371/journal.pone.0311677.r002

Author response to Decision Letter 0


20 Sep 2024

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Thank you, we have updated the formatting to meet PLOS ONE’s requirements.

2. We noted in your submission details that a portion of your manuscript may have been presented or published elsewhere. [This work was presented at the virtual Lancet Public Health Science conference in November 2021 and the submitted abstract was published (https://doi.org/10.1016/S0140-6736(21)02627-1). This work originally formed part of the thesis for a Doctor of Philosophy degree undertaken by Elizabeth Taylor and funded by NIHR Southampton Biomedical Research Centre and University of Southampton Primary Care, Population Sciences and Medical Education PhD studentship. The thesis is under embargo until October 2024.] Please clarify whether this [conference proceeding or publication] was peer-reviewed and formally published. If this work was previously peer-reviewed and published, in the cover letter please provide the reason that this work does not constitute dual publication and should be included in the current manuscript.

The abstract was reviewed by the conference organising committee for decision making on acceptance of abstract to the conference programme. The short abstract was published in a supplement of the Lancet which is the usual practice for this conference’s accepted abstracts every year. This does not constitute dual publication as the conference abstract does not include the full introduction, methods, results and discussion included in the paper.

3. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

Please update your Data Availability statement in the submission form accordingly

We have edited the data availability statement as follows: The study’s ethical approval from the Faculty of Medicine Ethics Committee, University of Southampton and the Health Research Authority restricts public sharing of the raw data used in this study. To request access conditional on approval from the appropriate institutional ethics, research governance processes and data owners, please email rgoinfo@soton.ac.uk.

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Thank you, we have reviewed the reference list as suggested.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer #1:

Introduction: The introduction is clear and concise, but the literature cited is very global, none on the context where the study is conducted. Suggestion: include more contextual information including the problem and the gaps that the study addresses.

Thank you. Further detail has now been included in the introduction to address the reviewer’s comments (lines 50-54 and 58-63). These pick up on the specific prevalence of children with obesity in the UK and add more contextual detail.

Methods: Very well and clearly detailed. Thank you.

Results: Well detailed, aligned with the objectives and statistical analysis. However, quite difficult to follow, the author should add sub-topics representing the different sub-objectives / scenarios for clarity.

Thank you, sub-headings have now been added to aid clarity.

Reviewer #2:

An excellent paper. Well written, conceived and interesting. Results support the need for good pre- / inter-conception strategies to optimise maternal health and mitigate childhood risks. Thank you.

A few minor comments and suggests for the author(s):

Methods:

1. What is your rationale for excluding women who conceived via artificial reproductive therapy? This should be more clearly described and discussed in the paper. With increasing maternal age, more women are seeking to conceive via ART. Often BMI restrictions in the private sector are less closely adhered to than in the NHS. It is important that full representation of the pregnant population is described.

Thank you. Women who conceived one or both of their first two pregnancies using assisted reproductive technologies have been excluded to reduce any potential for residual confounding because of unmeasured health changes associated with this very heterogeneous group of interventions. Few exclusions were made for this reason (n = 309). The manuscript has been updated to be more specific for the reason for this exclusion (lines 100-102).

2. Exposure assessment - please state that the chosen BMI classes reflect a truncated WHO classification (REF).

Thank you, this has now been included as suggested (lines 117-118).

Results:

1. Table 3: gestational age could be more meaningful to present as weeks and days depending on readership. It may be clearer to include both this in additional to gestational age in days.

Thank you. For clarity, a footnote has been added to the Table to state that 280 days is equivalent to 40 weeks gestation.

2. Table 3: please check that units are clearly presented for all variables (e.g) weight change between pregnancies (%) in table 3.

Thank you, the second line of the table heading was omitted in error and has now been re-instated to show “All figures are proportions (%) unless stated otherwise.”

3. Abbreviations 3 and 4 are not described in the footnotes for table 3, please amend.

Thank you, these have now been replaced with a description, to be consistent with the entries for the second child. The abbreviations in the table have also been updated.

4. What was your rationale for significant weight gain (3 kg or more)? Please describe why in the manuscript.

Thank you. A brief description of the rationale with appropriate references has now been added to the manuscript (lines 291-293).

Discussion:

Well thought through and presented. Further discussion could include influence of recent maternity and public health strategies to support your proposed interventions. For example, the Women’s Health Strategy for England.

https://www.gov.uk/government/publications/womens-health-hubs-information-and-guidance/womens-health-hubs-core-specification

Thank you very much. A brief reference to this has now been included in the paper in the context of delivering interventions (lines 317-319).

Attachment

Submitted filename: Response-to-reviewers-effect-IPchanges _final.docx

pone.0311677.s001.docx (20.9KB, docx)

Decision Letter 1

Engelbert Adamwaba Nonterah

24 Sep 2024

Quantifying the effect of interpregnancy maternal weight and smoking status changes on childhood overweight and obesity in a UK population-based cohort

PONE-D-24-08911R1

Dear Dr. Nida Ziauddeen,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Engelbert A. Nonterah, MD, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Engelbert Adamwaba Nonterah

27 Sep 2024

PONE-D-24-08911R1

PLOS ONE

Dear Dr. Ziauddeen,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Engelbert Adamwaba Nonterah

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response-to-reviewers-effect-IPchanges _final.docx

    pone.0311677.s001.docx (20.9KB, docx)

    Data Availability Statement

    The study’s ethical approval from the Faculty of Medicine Ethics Committee, University of Southampton and the Health Research Authority restricts public sharing of the raw data used in this study. To request access conditional on approval from the appropriate institutional ethics, research governance processes and data owners, please email rgoinfo@soton.ac.uk.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES